Dr. Stephen Nicol, world-renowned expert on krill sustainability and scientific advisor to the Association of Responsible Krill Harvesting Companies (ARK), spoke on behalf of ARK earlier this month at the Omega-3 Symposium in Sydney, Australia.
The Omega-3 Centre and Sydney Fish Market hosted the event to discuss the sustainability of long-chain omega-3 ingredients and the commercial consequences and impact on health benefits. Discussions ranged from updates on the science behind omega-3 health benefits, to a look at global omega-3 demand and supply including novel sources of long chain omega-3s. Dr. Nicol joined a panel of international speakers and experts to discuss krill and sustainability.
"The joint efforts of CCAMLR management, industry, and scientific researchers are working together to ensure that the fishery for krill is one of the world's best managed fisheries and that the needs of the ecosystem are accounted for," said Dr. Nicol, adding that the the effective management of the krill fishery has likely succeeding in ensuring its sustainability. "The krill fishery may be the only fishery in the world that is only at 2.3% of its potential catch rate. With a highly precautionary management regime, the fishery has operated for 40 years with no indication that it has had any effect on krill stocks or their predators."
"The krill fishery will always be controversial," Dr. Nicol acknowledged in his presentation. "Sectors of the krill fishing industry are aware of the concern over harvesting krill and are working together and with conservation groups to ensure that the fishery is sustainable in the long-term - and is viewed as such by the general public." Dr. Nicol is also a member of the Aker BioMarine Science Advisory Board (ASB).
According to GOED (Global Organization for EPA and DHA Omega-3) statistics, there has been substantial growth in consumption of EPA & DHA-rich oils in the past 10 years, leading to an increased demand. Concerns about sustainability of the traditional sources of these essential fatty acids has led to increased interest in and sales of novel sources, such as krill. Krill phospholipids offer a very bioefficient source of omega-3 EPA & DHA. Considering that omega -3 phospholipids provide the benefit of increased bioefficiency from a highly sustainable resource, makes krill a very desirable source of these essential nutrients.
About Aker BioMarine Antarctic
Aker BioMarine Antarctic is the only krill ingredient marketer that is primary in its supply. Aker BioMarine Antarctic's proprietary Eco-Harvesting(TM) technology and on-board processing result in the unique composition of Superba(TM) Krill Oil and provide full traceability from sea to shelf. The Marine Stewardship Council (MSC) has granted MSC Certification to Aker BioMarine Antarctic's fisheries, an exclusive distinction. As part of an established commitment to substantiating krill's health benefits, Aker BioMarine Antarctic continues to sponsor in vitro, in vivo, and human clinical trials with phospholipid EPA & DHA from krill oil, consistently demonstrating a higher uptake of phospholipid omega-3 fatty acids, improved blood lipid profiles, and increased uptake of DHA in brain tissue compared to other omega-3 fatty acid sources.
The Aker Science Board brings together internationally recognized scientific experts who will join with Aker BioMarine Antarctic's staff scientists to discuss the commercial and regulatory landscape for krill phospholipid omega-3s and the global demands for increased omega-3 consumption and supplementation. Given the international scope of Aker BioMarine Antarctic's business, the members of the ASB provide diverse council from many complementary disciplines and combine to offer a global perspective, providing strategic guidance for ongoing research and development.